Ginkgo touts gene therapy one-stop shop capabilities following acquisition 11-Apr-2023 By Ben Hargreaves Ginkgo acquires StrideBio's adeno-associated virus (AAV) capsid discovery and engineering platform assets and as well as gaining ownership of a preclinical asset.